![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Richette Pascal Bardin Thomas
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.11, Iss.17, 2010-12, pp. : 2933-2938
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oral Colchicine (Colcrys®): In the Treatment and Prophylaxis of Gout
Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oral Colchicine (Colcrys®) in the Treatment and Prophylaxis of Gout†: Profile Report
Drugs & Aging, Vol. 27, Iss. 10, 2010-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gout in the Elderly: Clinical Presentation and Treatment
By Fam A.G.
Drugs & Aging, Vol. 13, Iss. 3, 1998-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Febuxostat aims for the apex of gout treatment
Inpharma, Vol. 1, Iss. 1520, 2006-01 ,pp. :